Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03029-6 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Sisi Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Southwest Hospital, Army Medical University, No.30, Gaotanyan Street, Shapingba District, Chongqing, 400038, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Severity of Illness Index. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Southwest Hospital, Army Medical University, No.30, Gaotanyan Street, Shapingba District, Chongqing, 400038, China.
- Department of Dermatology, Southwest Hospital, Army Medical University, No.30, Gaotanyan Street, Shapingba District, Chongqing, 400038, China. drsongzq@tmmu.edu.cn.
Zitieren
APA
Deng, S., Wang, H., Chen, Q., Chen, X., Song, X., Chen, S., Kong, M., & Song, Z. (2024). Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03029-6
Vancouver
Deng S, Wang H, Chen Q, Chen X, Song X, Chen S, et al. Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03029-6
BibTeX
@article{Deng2024,
author = {Deng, Sisi and Wang, Huan and Chen, Qiquan and Chen, Xueqin and Song, Xiao and Chen, Shuguang and Kong, Minmin and Song, Zhiqiang},
title = {Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03029-6}
}
EUVIMED